Hepatitis C virus-associated glomerulonephritis.
Tang SC, Lai KN.
Contrib Nephrol. 2013;181:194-206. doi: 10.1159/000348477. Epub 2013 May 8.
Hepatitis C virus-associated glomerulonephritis.
Stehman-Breen C, Willson R, Alpers CE, Gretch D, Johnson RJ.
Curr Opin Nephrol Hypertens. 1995 May;4(3):287-94. doi: 10.1097/00041552-199505000-00015.
Hepatitis Virus C-associated Nephropathy: A Review and Update.
Habas E Sr, Farfar KL, Errayes N, Habas AM, Errayes M, Alfitori G, Rayani A, Elgara M, Al Adab AH, Elzouki A.
Cureus. 2022 Jul 27;14(7):e27322. doi: 10.7759/cureus.27322. eCollection 2022 Jul.
Cryoglobulinemia: An update in 2019.
Desbois AC, Cacoub P, Saadoun D.
Joint Bone Spine. 2019 Nov;86(6):707-713. doi: 10.1016/j.jbspin.2019.01.016. Epub 2019 Feb 4.
Hepatitis C virus-associated glomerulonephritis.
Stehman-Breen C, Johnson RJ.
Adv Intern Med. 1998;43:79-97.
Hepatitis C virus associated glomerulopathies.
Ozkok A, Yildiz A.
World J Gastroenterol. 2014 Jun 28;20(24):7544-54. doi: 10.3748/wjg.v20.i24.7544.
Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.
Montero N, Favà A, Rodriguez E, Barrios C, Cruzado JM, Pascual J, Soler MJ.
Cochrane Database Syst Rev. 2018 May 7;5(5):CD011403. doi: 10.1002/14651858.CD011403.pub2.
Cryoglobulinemia.
Killeen RB, Awais M, Mikes BA.
2025 Mar 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Hepatitis C virus-related cryoglobulinemic vasculitis.
Mazzaro C, Mauro E, Ermacora A, Doretto P, Fumagalli S, Tonizzo M, Toffolutti F, Gattei V.
Minerva Med. 2021 Apr;112(2):175-187. doi: 10.23736/S0026-4806.20.07120-7. Epub 2020 Nov 16.
Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report.
Shimada M, Nakamura N, Endo T, Yamabe H, Nakamura M, Murakami R, Narita I, Tomita H.
BMC Nephrol. 2017 Mar 29;18(1):109. doi: 10.1186/s12882-017-0534-5.
